BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 26
• 27
• 28
• 29

• Drug Development

  Boehringer Ingelheim Pharmaceuticals, Inc. Release: Positive Phase 3 Results For New Fixed Oral Dose Anticoagulant Presented At 48th Annual Meeting Of The American Society of Hematology

  December 11, 2006

   · 

  7 min read
• BioMidwest

  Ceragenix Pharmaceuticals, Inc. Completes $5 Million Financing

  December 11, 2006

   · 

  1 min read
• Business

  Clearant, Inc. Announces Agreement To Expand Its Direct Distribution Growth Initiative (R) To The Sports Medicine Market In The New York Region

  December 11, 2006

   · 

  1 min read
• Drug Development

  Leeds Teaching Hospitals Release: Final Data From Phase III Study Show Single-Agent Alemtuzumab (Campath(R), MabCampath(R)) Superior To Chlorambucil For Patients With Previously Untreated B-CLL

  December 11, 2006

   · 

  4 min read
• Policy

  Sanofi-Aventis (France) And Bristol-Myers Squibb Company Release: Preliminary Injunction Against Apotex Inc. Upheld On Appeal

  December 11, 2006

   · 

  4 min read
• Business

  NGN Capital’s Managing General Partner Georg Nebgen Joins Javelin Pharmaceuticals Board Of Directors

  December 11, 2006

   · 

  1 min read
• Drug Development

  Novartis Pharmaceuticals Corporation Release: Pivotal Submission Data Shows Tasigna(R) Achieved Impressive Response Rates In Chronic Myeloid Leukemia Patients No Longer Helped By Gleevec(R)

  December 11, 2006

   · 

  12 min read
• Drug Development

  Telik, Inc. Announces Positive Data Demonstrating That TELINTRA(TM) Enhances Production Of G-CSF And GM-CSF

  December 11, 2006

   · 

  2 min read
• Drug Development

  INNOVIVE Pharmaceuticals Announces Preliminary Phase I Data Of INNO-406 As A Therapeutic For Treatment Resistant Or Intolerant Chronic Myelogenous Leukemia

  December 11, 2006

   · 

  5 min read
• Business

  Clinical Data, Inc. And LAB21, Inc Launch Cardiac Channelopathy Genetic Test In United Kingdom & Ireland

  December 11, 2006

   · 

  1 min read